Pregnancy and Lactation Labeling Rule (PLLR): Implications for Clinical Practice

April 18, 2017

This webinar will start at 10:00 am Central on April 18, 2017. Before joining, be sure to check system requirements to avoid any connection issues.

Pregnancy and Lactation Labeling Rule (PLLR): Implications for Clinical Practice will review the changes in labeling due to the PLLR, and current implementation strategies and timelines. Clinicians will review what this means for day-to-day practice and present a variety of strategies for patient engagement and education. Information on current surveillance efforts to determine medication safety in the pregnancy/lactation period will be provided.

Target Audience

  • Allergist/immunologists
  • Obstetricians/gynecologists
  • Nurse practitioners
  • Pharmacists
  • Primary care physicians
  • Allied health professionals

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe how the PLLR provides improved information on drug safety data for pregnant and lactating women
  • Identify three strategies clinicians can use in their day-to-day practice to inform their pregnant and lactating patients about the PLLR
  • Describe one method for evaluating the safety of medications during pregnancy and the lactation period
Summary
Available credit: 
  • 1.00 CE
    CE credit.
  • 1.00 CME
    CME credit.
Course opens: 
04/03/2017
Course expires: 
12/31/2017
Event starts: 
04/18/2017 - 9:00am CDT
Event ends: 
04/18/2017 - 10:10am CDT
Cost:
$0.00
Add to calendar: 
Rating: 
0

Planning Committee
Michael Schatz, MD MS FAAAAI
Kaiser Permanente, San Diego, CA
Relevant relationships: GSK: Advisory Board; AstraZeneca/Medimmune, GSK, Merck: Research Grant

Allen Mitchell, MD
Slone Epidemiology Center, Boston, MA
Relevant relationships: None

Kenneth Lyons Jones, MD
University of California - San Diego, San Diego, CA
Relevant relationships: None

Carla Van Bennekom, MPH
Slone Epidemiology Center, Boston, MA
Relevant relationships: None

Leyla Sahin, MD
Food and Drug Admininstration, Silver Spring, MD
Relevant relationships: None

Alison Bryant Mantha, MD
Massachusetts General Hospital,  Boston, MA
Relevant relationships: None

Christina Chambers, PhD MPH
University of California School of Medicine, San Diego, CA
Relevant relationships: Amgen, Apotex Inc./Barr Labs Inc., Celegene, GSK, Hoffman La Roche, Janssen Biotche Inc. Pfizer, Sanofi, Takeda, Genzyme: Research Grant

Faculty
Michael Schatz, MD MS FAAAAI
Kaiser Permanente, San Diego, CA
Relevant relationships: GSK: Advisory Board; AstraZeneca/Medimmune, GSK, Merck: Research Grant

Alison Bryant Mantha, MD
Massachusetts General Hospital,  Boston, MA
Relevant relationships: None

Christina Chambers, PhD MPH
University of California School of Medicine, San Diego, CA
Relevant relationships: Amgen, Apotex Inc./Barr Labs Inc., Celegene, GSK, Hoffman La Roche, Janssen Biotche Inc. Pfizer, Sanofi, Takeda, Genzyme: Research Grant

Leyla Sahin, MD
Food and Drug Admininstration, Silver Spring, MD
Relevant relationships: None

CME/MOC Reviewers

Anne Ditto, MD FAAAAI
Northwestern University Feinberg School of Medicine, Chicago, IL
Relevant relationships: None

Sara Lowe, NP
Medical College of Wisconsin, Milwaukee, WI
Relevant relationships: None

Available Credit

  • 1.00 CE
    CE credit.
  • 1.00 CME
    CME credit.

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.

Internet Explorer is no longer supported.